Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / FOLD - Amicus Therapeutics reports mixed Q2 earnings; reaffirms FY22 guidance

FOLD - Amicus Therapeutics reports mixed Q2 earnings; reaffirms FY22 guidance

Amicus Therapeutics Inc.
  • Amicus Therapeutics press release ( NASDAQ: FOLD ): Q2 GAAP EPS of -$0.21 beats by $0.01 .
  • Revenue of $80.7M (+4.3% Y/Y) misses by $5.18M .
  • For the full-year 2022, the company anticipates total Galafold revenue of $350 million to $365 million at constant exchange rates.
  • Non-GAAP operating expense guidance for the full-year 2022 is $470 million to $485 million.

For further details see:

Amicus Therapeutics reports mixed Q2 earnings; reaffirms FY22 guidance
Stock Information
Company Name: Amicus Therapeutics Inc.
Stock Symbol: FOLD
Market: NASDAQ
Website: amicusrx.com
Menu
FOLD FOLD Quote FOLD Short FOLD News FOLD Articles FOLD Message Board
Get FOLD Alerts

News, Short Squeeze, Breakout and More Instantly...